Episurf: Results from study with Episealer® Knee implant accepted for presentation at Swedish orthopaedic congress
The abstract reports on the clinical outcome for patients having undergone treatment with Episurf Medical's personalised knee implant Episealer® for treatment of isolated chondral and osteochondral defects in the knee, at Stockholm South Hospital.
"The study performed at Stockholm South Hospital is the first prospective, investigator-initiated study with follow up of Episealer® patients. We highly appreciate this initiative, and we are happy that the Swedish Orthopaedic Society decided to accept this abstract for a podium presentation, which confirms the interest in the clinical results of our technology. We are looking forward to taking part of the results from this ongoing study", says Pål Ryfors, CEO Episurf Medical.